Veracyte (VCYT) Receivables - Net (2012 - 2026)

Veracyte has disclosed Receivables - Net across 15 years of filings, most recently posting $54.2 million for Q2 2026.

• In Q2 2026, Receivables - Net rose 6.62% year-over-year to $54.2 million; the TTM figure through Jun 2026 stood at $54.2 million (up 6.62% YoY), while the FY2025 annual figure was $44.7 million, down 4.01% from the prior year.
• Receivables - Net came in at $54.2 million for Q2 2026 at Veracyte, up from $50.1 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $54.2 million in Q2 2026 to a low of $39.3 million in Q3 2023.
• Average Receivables - Net over 5 years is $46.0 million, with a median of $46.0 million recorded in 2023.
• Year-over-year, Receivables - Net surged 52.39% in 2022 and declined 8.28% in 2023.
• Over 5 years, Receivables - Net stood at $44.0 million in 2022, then dropped by 8.28% to $40.4 million in 2023, then rose by 15.22% to $46.5 million in 2024, then fell by 4.01% to $44.7 million in 2025, then gained by 21.31% to $54.2 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $54.2 million in Q2 2026, $50.1 million in Q1 2026, and $44.7 million in Q4 2025.